WESTFIELD, IN — Abbott, a global health care company, plans to establish a new medical device manufacturing and assembly site along U.S. Highway 31 in Westfield, Indiana.
Abbott is investing at least $37.6 million to launch a new manufacturing site for its structural heart business, constructing a 120,000-square-foot facility in Westfield. This will add more than 450 new jobs over the next several years.
Once complete, the new space will house production of Abbott’s MitraClip transcatheter mitral valve repair system, which is also manufactured in Menlo Park, California, enabling the company to increase production and better serve its global customers. Construction is set to begin later this year, with the space expected to be fully operational by the end of 2021.
"We're pleased to expand our U.S. presence by building an additional MitraClip manufacturing facility in Indiana,” says Mike Dale, Vice President of Abbott’s structural heart business. “This facility will help in our goal to improve the health of people around the world and meet the needs of physicians and patients battling structural heart disease.”
The Indiana Economic Development Corporation (IEDC) offered Abbott up to $3.5 million in conditional tax credits and up to $1 million in training grants based on the company’s plans to create more than 300 jobs by the end of 2024. The IEDC also offered up to $750,000 to the community from the Industrial Development Grant Fund to support infrastructure improvements to the new site.
